Arjo AB (publ)
STO:ARJO B
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
32.84
52.1383
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Arjo AB (publ)
Arjo AB (publ)
Research & Development
Arjo AB (publ)
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Arjo AB (publ)
STO:ARJO B
|
Research & Development
-kr149m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Research & Development
-kr830m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Research & Development
-kr185.7m
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-65%
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Research & Development
-kr86.3m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-16%
|
|
|
Getinge AB
STO:GETI B
|
Research & Development
-kr1.1B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
S
|
Stille AB
STO:STIL
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Arjo AB (publ)
Glance View
Arjo AB engages in the provision of medical devices and solutions. The company is headquartered in Malmo, Skane and currently employs 6,350 full-time employees. The company went IPO on 2017-12-12. The Company’s offering includes products and solutions within the product segments Patient handling, Hygiene, Disinfection, Therapeutic surfaces, Venous Thromboembolism (VTE) prevention and Diagnostics. Additionally, the Company is offering its customers complementing services. The products comprise ceiling lifts, standing and raising aids, slings, floor lifters, among others. Arjo AB (publ) operates in more than 60 countries, which the Company divides into three geographical areas: North America, Western Europe and Rest of the World.
See Also
What is Arjo AB (publ)'s Research & Development?
Research & Development
-149m
SEK
Based on the financial report for Dec 31, 2023, Arjo AB (publ)'s Research & Development amounts to -149m SEK.
What is Arjo AB (publ)'s Research & Development growth rate?
Research & Development CAGR 5Y
-1%
Over the last year, the Research & Development growth was -30%. The average annual Research & Development growth rates for Arjo AB (publ) have been -9% over the past three years , -1% over the past five years .
You don't have any saved screeners yet
